Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > About time for a POP!

<< Previous

Bullboard Posts

Next >>

Comment by MrMonkon Dec 27, 2013 6:32pm

104 Views

Post# 22041389

RE:About time for a POP!

I still like this company very much. All the right things in place - good resource with plenty of upside, strong management and advisory team, mining-friendly jurisdiction and some cash in the till. All we need now is for buillion pricing to resume its upward trend and for interest to return to the mining/exploration sectors. Remaining solvent is the name of the game in this sector at the present time and I firmly believe NOX can ride out the storm.

At 0.085, you're in a very good spot.

- MM

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects